Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.61 0.00 (-0.42%)
As of: Sep 9, 2026 · 3:59 PM EDT

Adagio Medical Holdings (ADGM) Notes Payables (2023)

Adagio Medical Holdings' (ADGM) quarterly Notes Payables came in at $36.4 million in Q4 2023.

Analysis

Adagio Medical Holdings (ADGM) Notes Payables (2023) Analysis & Trends

Adagio Medical Holdings has disclosed Notes Payables across 1 years of filings, most recently posting $36.4 million for Q4 2023.

  • In Q4 2023, Notes Payables changed N/A year-over-year to $36.4 million; the TTM figure through Dec 2023 stood at $36.4 million (changed N/A YoY), while the FY2023 annual figure was $36.4 million, changed N/A from the prior year.
  • Notes Payables came in at $36.4 million for Q4 2023 at Adagio Medical Holdings.
  • In the past five years, Notes Payables ranged from a high of $36.4 million in Q4 2023 to a low of $36.4 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Adagio Medical Holdings 13.45 Mn 13.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 36.43 Mn